Will AstraZeneca's stock (AZN) close above its price on the day of the FDA panel vote ($72.00) by September 30, 2027?

AstraZeneca's stock fell after the FDA panel vote, indicating market concern. The stock's recovery will depend on future drug pipeline news and overall market performance.

Implied probability (Yes)

40%

Closes

2029-07-30